AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 22nd, 2020 • Scopus BioPharma Inc. • Pharmaceutical preparations • New York
This Amended and Restated Employment Agreement (this “Agreement”) is dated the 10th day of June, 2020, between Scopus BioPharma Inc., a Delaware corporation (“Company”), and Ashish P. Sanghrajka (“Executive”).
exclusive LICENSE AGREEMENTExclusive License Agreement • July 22nd, 2020 • Scopus BioPharma Inc. • Pharmaceutical preparations • California
THIS EXCLUSIVE LICENSE AGREEMENT (the “Agreement”) is made and entered into as of the 10th day of June 2020 (the “Effective Date”) by and between Scopus BioPharma Inc., a Delaware corporation with a principal place of business at 420 Lexington Avenue, New York, New York 10170 (“Scopus”), and City of Hope, a California nonprofit public benefit corporation located at 1500 East Duarte Road, Duarte, California 91010 (“City of Hope” or “COH”). Scopus and COH are each sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
CONDITIONAL STOCK PURCHASE AGREEMENT by and among SCOPUS BIOPHARMA INC. and THE SELLERS PARTY HERETO dated as of June 8, 2020 CONDITIONAL STOCK PURCHASE AGREEMENTConditional Stock Purchase Agreement • July 22nd, 2020 • Scopus BioPharma Inc. • Pharmaceutical preparations • New York
This CONDITIONAL STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of June 8, 2020, is entered into among (i) Scopus BioPharma Inc., a Delaware corporation (“Purchaser”), (ii) Bioscience Oncology Pty Ltd (ACN: 632 972 395), a corporation organized under the laws of Australia (the “Company”), (iii) Paul Hopper, an individual and the founder and initial shareholder of the Company (“Hopper”) and (iv) the additional parties who are signatories to this Agreement, each of whom is individually referred to as a “Seller” and collectively referred to as “Sellers”. Purchaser, the Company and the Sellers, are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
